FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Infinium Pharmachem IPO and Maiden Forgings IPO.
Infinium Pharmachem IPO is a SME Book Built Issue IPO proposed to list at NSE SME while Maiden Forgings IPO is a SME Book Built Issue proposed to list at BSE SME.
Infinium Pharmachem IPO | Maiden Forgings IPO | |
---|---|---|
Logo | ||
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Fixed Price Issue | Book Built Issue |
Listing At | NSE SME | BSE SME |
Lead Managers | Swastika Investmart Ltd | Share India Capital Services Private Limited |
Registrar | Bigshare Services Pvt Ltd | Maashitla Securities Private Limited |
Market Maker | Swastika Investmart Limited | Share India Securities Limited |
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | ||
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Infinium Pharmachem IPO is up to ₹25.26 Cr whereas the issue size of the Maiden Forgings IPO is up to ₹23.84 Cr. The final issue price of Infinium Pharmachem IPO is ₹135.00 per share and of Maiden Forgings IPO is ₹63.00 per share.
Infinium Pharmachem IPO | Maiden Forgings IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹60.00 per share | |
Issue Price (Upper) | ₹63.00 per share | |
Issue Price (Final) | ₹135.00 per share | ₹63.00 per share |
Discount (Retail) | ||
Discount (Employee) | ₹13.50 per share | |
Market Lot Size | 1000 shares | 2000 shares |
Fresh Issue Size | 18,75,000 shares | 37,84,000 shares |
Fresh Issue Size (Amount) | up to ₹25.26 Cr | up to ₹23.84 Cr |
OFS Issue Size | ||
OFS Issue Size (Amount) | ||
Issue Size Total | 18,75,000 shares | 37,84,000 shares |
Issue Size Total (Amount) | up to ₹25.26 Cr | up to ₹23.84 Cr |
Infinium Pharmachem IPO opens on Mar 31, 2023, while Maiden Forgings IPO opens on Mar 23, 2023. The closing date of Infinium Pharmachem IPO and Maiden Forgings IPO is Apr 05, 2023, and Mar 27, 2023, respectively.
Infinium Pharmachem IPO | Maiden Forgings IPO | |
---|---|---|
Anchor Bid Date | Mar 22, 2023 | |
Issue Open | Mar 31, 2023 | Mar 23, 2023 |
Issue Close | Apr 05, 2023 | Mar 27, 2023 |
Basis Of Allotment (Tentative) | Apr 11, 2023 | Mar 31, 2023 |
Initiation of Refunds (Tentative) | Apr 12, 2023 | Apr 03, 2023 |
Credit of Share (Tentative) | Apr 13, 2023 | Apr 05, 2023 |
Listing date (Tentative) | Apr 17, 2023 | Apr 06, 2023 |
Anchor Lockin End date 1 | May 11, 2023 | Apr 30, 2023 |
Anchor Lockin End date 2 | Jul 10, 2023 | Jun 29, 2023 |
Infinium Pharmachem IPO P/E ratio is 7.83, as compared to Maiden Forgings IPO P/E ratio of 8.38.
Infinium Pharmachem IPO | Maiden Forgings IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 100% | 100% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 73.05% | 73.37% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 7.83 | 8.38 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹93.93 Cr. | ₹89.54 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW |
In the Infinium Pharmachem IPO retail investors (RII) are offered 9,37,500 shares while in Maiden Forgings IPO retail investors are offered 9,37,500 shares. Qualified institutional buyers (QIB) are offered 0 shares in Infinium Pharmachem IPO and 3,60,000 shares in Maiden Forgings IPO.
Infinium Pharmachem IPO | Maiden Forgings IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | 94,000 shares | 1,90,000 shares |
QIB | 0 shares | 3,60,000 shares |
NII | 9,37,500 shares | 9,70,000 shares |
RII | 9,37,500 shares | 22,64,000 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 18,75,000 shares | 37,84,000 shares |
Infinium Pharmachem IPO subscribed 1.84x in total, whereas Maiden Forgings IPO subscribed 1.20x.
Infinium Pharmachem IPO | Maiden Forgings IPO | |
---|---|---|
QIB (times) | 1.00x | |
NII (times) | 1.80x | 1.42x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 1.86x | 1.12x |
Employee (times) | ||
Other (times) | ||
Total (times) | 1.84x | 1.20x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|